• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Zika virus envelope Recombinant Protein

Scan QR to view Datasheet
Catalog # MBS5304720
Unit / Price
  0.1 mg  /  $410 +1 FREE 8GB USB
  1 mg  /  $3,325 +4 FREE 8GB USB
SDS-PAGE analysis of Zika virus envelope protein
Product Name

Zika virus envelope, Recombinant Protein

Popular Item
Also Known As

Zika virus envelope protein; ZK envelope protein

Product Synonym Names
Zika ENV protein; Zika virus E protein; Zika envelope protein; Zika protein; Zika virus antigen; recombinant Zika protein; recombinant Zika antigen; Zika virus envelope antigen; recombinant Zika envelope protein; recombinant Zika envelope antigen; ZIKV protein; ZIKV antigen; ZIKV envelope
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Purity/Purification
> 85% by SDS-PAGE. Single band visible.
Form/Format
Supplied as liquid in PBS buffer, pH 7.4 with 0.05% sodium azide
Concentration
3.2 mg/ml by Bradford assays (lot specific)
Expression System
Insect cells
Grade
Recombinant
Source
Baculovirus derived recombinant protein consisting of amino acids 291-690 expressed in an insect cell line.
Biohazard
Use standard laboratory precautions when handling this material.
Residues
Zika virus envelope (E protein) comprising amino acids 291-690.
Species
Viral
Biological Significance
Zika virus spreads to people primarily through the bite of an infected Aedes species mosquito, but it can also be sexually transmitted. Zika virus was first discovered in 1947 and is named after the Zika Forest in Uganda. In 1952, the first human cases of Zika were detected. Zika virus has become a highly researched disease due to increase in incidences from 2007 to 2016, when the virus spread eastward, across the Pacific Ocean to the Americas. In 2015–16 Zika virus epidemic reached pandemic levels. The Zika envelope (E) protein composes the majority of the virion surface and it is involved with replication, such as host cell binding and membrane fusion.
Implications in Disease
The symptoms of Zika infection vary from non-existant to visible rash, fever, headaches and conjunctivitis. It is usually non life threatening, but has been associated to microcephaly in unborn fetuses when passed by an infected pregnant mother.
Sequence Information
The sequence of the envelope protein is derived from the African strain (all strains share very high identity in this region).
Preparation and Storage
Upon receipt store at or below -20 degree C. Avoid repeated freeze thaw cycles.
Shipping: Dry Ice.
Other Notes
Small volumes of Zika virus envelope recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
Zika virus envelope recombinant protein
Recombinant Zika virus envelope protein
Applications Tested/Suitable for Zika virus envelope recombinant protein
ELISA (EIA), Lateral Flow

SDS-PAGE analysis of Zika virus envelope protein of Zika virus envelope recombinant protein
Coomassie stained SDS-PAGE gel showing Zika envelope protein migrating at approximately 50 kDa.
Zika virus envelope recombinant protein SDS-PAGE analysis of Zika virus envelope protein  image
Molecular Weight
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000